News
Merck KGaA's $11.3 Billion Bio-Techne Deal: Why Europe's Biggest Life Sciences Bet in a Decade Is About More Than Reagents
There is a number that captures the ambition of what Merck KGaA announced on Thursday morning: 11.3. That is how many billion dollars the German science and technology giant has agreed to pay for Bio-Techne Corporation, a Minneapolis-based life sciences tools company that most investors outside the